88639313
Oct 2, 2019
ALNYLAM PHARMACEUTICALS INC.
Subscribe
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy